GTBP
Price
$0.81
Change
-$0.01 (-1.22%)
Updated
Sep 24, 12:04 PM (EDT)
Capitalization
2.93M
RAPT
Price
$22.84
Change
+$1.88 (+8.97%)
Updated
Sep 24, 12:25 PM (EDT)
Capitalization
346.63M
Interact to see
Advertisement

GTBP vs RAPT

Header iconGTBP vs RAPT Comparison
Open Charts GTBP vs RAPTBanner chart's image
GT Biopharma
Price$0.81
Change-$0.01 (-1.22%)
Volume$100
Capitalization2.93M
RAPT Therapeutics
Price$22.84
Change+$1.88 (+8.97%)
Volume$800
Capitalization346.63M
GTBP vs RAPT Comparison Chart in %
Loading...
GTBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GTBP vs. RAPT commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTBP is a Buy and RAPT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (GTBP: $0.82 vs. RAPT: $20.96)
Brand notoriety: GTBP and RAPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GTBP: 52% vs. RAPT: 86%
Market capitalization -- GTBP: $2.93M vs. RAPT: $346.63M
GTBP [@Biotechnology] is valued at $2.93M. RAPT’s [@Biotechnology] market capitalization is $346.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GTBP’s FA Score shows that 1 FA rating(s) are green whileRAPT’s FA Score has 0 green FA rating(s).

  • GTBP’s FA Score: 1 green, 4 red.
  • RAPT’s FA Score: 0 green, 5 red.
According to our system of comparison, both GTBP and RAPT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GTBP’s TA Score shows that 6 TA indicator(s) are bullish while RAPT’s TA Score has 4 bullish TA indicator(s).

  • GTBP’s TA Score: 6 bullish, 2 bearish.
  • RAPT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GTBP is a better buy in the short-term than RAPT.

Price Growth

GTBP (@Biotechnology) experienced а -0.01% price change this week, while RAPT (@Biotechnology) price change was +18.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.34%. For the same industry, the average monthly price growth was +10.13%, and the average quarterly price growth was +53.93%.

Industries' Descriptions

@Biotechnology (+4.34% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RAPT($347M) has a higher market cap than GTBP($2.94M). RAPT YTD gains are higher at: 65.823 vs. GTBP (-72.954). GTBP has higher annual earnings (EBITDA): -9.61M vs. RAPT (-111.99M). RAPT has more cash in the bank: 169M vs. GTBP (5.23M). GTBP has less debt than RAPT: GTBP (0) vs RAPT (3.16M). GTBP (0) and RAPT (0) have equivalent revenues.
GTBPRAPTGTBP / RAPT
Capitalization2.94M347M1%
EBITDA-9.61M-111.99M9%
Gain YTD-72.95465.823-111%
P/E RatioN/AN/A-
Revenue00-
Total Cash5.23M169M3%
Total Debt03.16M-
FUNDAMENTALS RATINGS
GTBP vs RAPT: Fundamental Ratings
GTBP
RAPT
OUTLOOK RATING
1..100
1824
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9735
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GTBP's Valuation (15) in the null industry is somewhat better than the same rating for RAPT (77). This means that GTBP’s stock grew somewhat faster than RAPT’s over the last 12 months.

GTBP's Profit vs Risk Rating (100) in the null industry is in the same range as RAPT (100). This means that GTBP’s stock grew similarly to RAPT’s over the last 12 months.

GTBP's SMR Rating (100) in the null industry is in the same range as RAPT (100). This means that GTBP’s stock grew similarly to RAPT’s over the last 12 months.

RAPT's Price Growth Rating (35) in the null industry is somewhat better than the same rating for GTBP (97). This means that RAPT’s stock grew somewhat faster than GTBP’s over the last 12 months.

RAPT's P/E Growth Rating (100) in the null industry is in the same range as GTBP (100). This means that RAPT’s stock grew similarly to GTBP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GTBPRAPT
RSI
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 27 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
GTBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NETTF30.451.40
+4.83%
NetEase, Inc.
DTNOF1.50N/A
N/A
DNO ASA
BKUT513.80N/A
N/A
Bank of Utica (NY)
CTYP6.16N/A
N/A
Community Bankers (PA)
NGKSY18.02N/A
N/A
NITERRA CO LTD.

GTBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, GTBP has been loosely correlated with BDRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if GTBP jumps, then BDRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GTBP
1D Price
Change %
GTBP100%
+3.14%
BDRX - GTBP
39%
Loosely correlated
-4.76%
TRAW - GTBP
29%
Poorly correlated
-1.57%
PTCT - GTBP
28%
Poorly correlated
-0.48%
RAPT - GTBP
27%
Poorly correlated
+4.12%
SLGL - GTBP
27%
Poorly correlated
+2.86%
More

RAPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPT has been loosely correlated with TRAW. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RAPT jumps, then TRAW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPT
1D Price
Change %
RAPT100%
+4.12%
TRAW - RAPT
45%
Loosely correlated
-1.57%
SLGL - RAPT
39%
Loosely correlated
+2.86%
CTMX - RAPT
35%
Loosely correlated
+2.43%
AVXL - RAPT
34%
Loosely correlated
-2.63%
PDSB - RAPT
32%
Poorly correlated
-2.78%
More